MYB and adrenal cortex carcinoma: Furthermore, they identified the DNA-damage sensor kinase ataxia telangiectasia and Rad3-related (ATR) as a MYB downstream target that is overexpressed in primary ACCs and ACC-patient-derived xenografts [24].